Amphastar Pharmaceuticals (AMPH) Payables (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Payables of $35.5 million for Q1 2026, down 32.78% year-over-year from $52.8 million in Q1 2025, and down 76.07% quarter-over-quarter from $148.3 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Payables (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Payables history runs 14 years deep, the most recent figure standing at $35.5 million for Q1 2026.
- In Q1 2026, Payables fell 32.78% year-over-year to $35.5 million; the TTM figure through Mar 2026 stood at $35.5 million (down 32.78% YoY), while the FY2025 annual figure was $148.3 million, down 5.55% from the prior year.
- Payables for Q1 2026 stood at $35.5 million, down from $148.3 million in the prior quarter.
- The five-year high for Payables was $222.7 million in Q3 2023, with the low at $18.8 million in Q2 2023.
- The 5-year median for Payables is $84.2 million (2022), against an average of $84.6 million.
- The sharpest annual moves came in 2023 and 2024: Payables jumped 1015.66% in 2023, then tumbled 84.69% in 2024.
- Amphastar Pharmaceuticals' Payables stood at $84.2 million in 2022, then increased by 10.83% to $93.4 million in 2023, then surged by 68.22% to $157.1 million in 2024, then declined by 5.55% to $148.3 million in 2025, then plunged by 76.07% to $35.5 million in 2026.
- Business Quant data shows AMPH's Payables at $35.5 million in Q1 2026, $148.3 million in Q4 2025, and $40.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 986.00 Mn |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | 251.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 251.37 Mn |
| Mar 31, 2026 | 35.50 Mn |
| Dec 31, 2025 | 148.35 Mn |
| Sep 30, 2025 | 40.54 Mn |
| Jun 30, 2025 | 166.55 Mn |
| Mar 31, 2025 | 52.81 Mn |
| Dec 31, 2024 | 157.06 Mn |
| Sep 30, 2024 | 34.09 Mn |
| Jun 30, 2024 | 31.78 Mn |
| Mar 31, 2024 | 116.70 Mn |
| Dec 31, 2023 | 93.37 Mn |
| Sep 30, 2023 | 222.72 Mn |
| Jun 30, 2023 | 18.83 Mn |
| Mar 31, 2023 | 21.98 Mn |
| Dec 31, 2022 | 84.24 Mn |
| Sep 30, 2022 | 19.96 Mn |
| Jun 30, 2022 | 97.67 Mn |
| Mar 31, 2022 | 95.81 Mn |
| Dec 31, 2021 | 89.55 Mn |
| Sep 30, 2021 | 21.66 Mn |